|
|
|
|
Science Sparks @ ACTREC
|
 04 November 2024 |
Vol. No. 13 ; Issue No.655 |
|
|
Publications
|
|
1. Khanna D, Shruti T, Tiwari M, Sharma P, Khan A, Ranjan S, Balasundaram P, Khargekar N, Chaturvedi P, Mishra A (2024). Prevalence of Oral Potentially Malignant Lesions, Tobacco use, and Effect of Cessation Strategies among Solid Waste Management workers in Northern India: a pre-post intervention study. BMC Oral Health. 24(1):1292
2. Murthy V, Dal Pra A. (2024) Transporting testosterone home: Navigating the road to recovery. European Urology.
3. Han JX, Koh MJ, Boussi L, Sorial M, McCabe SM, Peng L, Singh S... Shet T, Epari S, Shetty A, Saha S, Jain H Dr, Sengar M…etal (2024). Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium. Blood Advances.
4. Ranjith C P , Krishnan M, Raveendran V, Chaudhari L, Laskar S (2024). Assessment of pencil beam scanning proton therapy beam delivery accuracy through machine learning and log file analysis. Physica Medica. 127:104854.
|
|
|
|
|
Interesting Reads
|
|
Liao Y, Chen Q, Liu L, Huang H, Sun J, Bai X, Jin C, Li H, Sun F, Xiao X, Zhang Y, Li J, Han W, Fu S (2024). Amino acid is a major carbon source for hepatic lipogenesis. Cell Metabolism.
|
|
|
Video of the Week
|
|
| Timely Integration of Oncology and Palliative Care: A Rapidly Evolving Paradigm |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2012,Vismodegib (Erivedge) was the first drug approved by FDA for basal cell carcinoma, the most common type of skin cancer.
|
|
|
|
Cancer News
|
| |
|
Study identifies six cancer susceptibility genes.
|
|
News-Medical, 29/10/2024
|
|
The study found that heterozygous loss of PPP1R15A is associated with a 53% lower risk of breast cancer. PPP1R15A encodes a key regulatory protein of the integrated stress response pathway, which is activated in response to various stress factors...
|
| |
|
Novel immunotherapy combo shows promise in melanoma
|
|
MedicalXpress, 01/11/2024
|
|
The findings support the development of vidutolimod for treating cutaneous melanoma and provide important insights that could advance research on this drug for use in other cancers...
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
